"Diphosphonates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents.
| Descriptor ID |
D004164
|
| MeSH Number(s) |
D02.705.429.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Diphosphonates".
Below are MeSH descriptors whose meaning is more specific than "Diphosphonates".
This graph shows the total number of publications written about "Diphosphonates" by people in this website by year, and whether "Diphosphonates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 1 | 3 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 3 | 5 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 2 | 3 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 2 | 3 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 2 | 4 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diphosphonates" by people in Profiles.
-
Preventing or controlling periodontitis reduces the occurrence of osteonecrosis of the jaw (ONJ) in rice rats (Oryzomys palustris). Bone. 2021 04; 145:115866.
-
Endocrine Conditions in Older Adults: Osteoporosis. FP Essent. 2018 Nov; 474:11-19.
-
Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in Korea. J Bone Miner Metab. 2019 May; 37(3):563-572.
-
What can we do about musculoskeletal pain from bisphosphonates? Cleve Clin J Med. 2018 09; 85(9):675-678.
-
Surgical Complications Associated With Atypical Femur Fractures Attributed to Bisphosphonate Use. J Surg Orthop Adv. 2018 Spring; 27(1):14-20.
-
Oncologic doses of zoledronic acid induce site specific suppression of bone modelling in rice rats. Orthod Craniofac Res. 2017 Jun; 20 Suppl 1:83-88.
-
Fibrous dysplasia. Clinical review and therapeutic management. Med Clin (Barc). 2016 Dec 16; 147(12):547-553.
-
Lack of scintigraphic response of fibrous dysplasia to bisphosphonate treatment. Rheumatology (Oxford). 2016 Oct; 55(10):1735.
-
Gorham-Stout Disease Successfully Treated With Sirolimus and Zoledronic Acid Therapy. J Pediatr Hematol Oncol. 2016 Apr; 38(3):e129-32.
-
A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma. PLoS One. 2015; 10(7):e0132520.